SELLAS Life Sciences Grou...

NASDAQ: SLS · Real-Time Price · USD
1.62
0.07 (4.52%)
At close: Aug 15, 2025, 3:59 PM
1.62
0.19%
After-hours: Aug 15, 2025, 07:58 PM EDT

SELLAS Life Sciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a -1M -1M -1M n/a -6.6M -6.6M -4.7M n/a 9.5M 9.5M 7.6M
Cost of Revenue
n/a n/a n/a n/a n/a 158K 245K 368K 575K 499K 512K 1.66M 1.46M 1.47M 1.47M 277K 277K 177K
Gross Profit
n/a n/a n/a n/a n/a -158K -245K -1.37M -1.57M -1.5M -512K -8.26M -8.05M -6.17M -1.47M 9.22M 9.22M 7.42M
Operating Income
-27.18M -27.93M -31.51M -32.77M -34.8M -36.23M -37.87M -39.14M -36.92M -36.5M -41.95M -44.12M -43.95M -39.78M -25.29M -17.83M -15.35M -15.16M
Interest Income
924K 803K 632K 492K 365K 422K 525K 642K 659K 497K 317K 159K 50K 6K 6K 7K 5K 4K
Pretax Income
-26.26M -27.13M -30.88M -32.28M -34.44M -35.81M -37.34M -38.33M -36.08M -35.65M -41.3M -39.02M -39.08M -35.28M -20.94M -17.83M -15.22M -15.03M
Net Income
-26.26M -27.13M -30.88M -32.28M -34.44M -35.81M -37.34M -38.33M -36.08M -35.65M -41.3M -38.78M -38.84M -35.04M -20.7M -17.82M -15.21M -15.02M
Selling & General & Admin
11.31M 10.74M 12.42M 13.02M 13.6M 14.29M 13.86M 14.38M 13.7M 13.66M 12.58M 11.51M 11.08M 10.78M 11.32M 12.08M 11.77M 10.96M
Research & Development
15.88M 17.19M 19.1M 19.76M 21.21M 21.94M 24.01M 24.76M 23.23M 22.83M 30.27M 33.52M 33.77M 31.7M 21.37M 15.05M 12.88M 11.7M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a 1.79M 1.79M 1.79M 11.79M 15.9M 15.9M 15.9M 5.9M n/a n/a n/a
Operating Expenses
27.18M 27.93M 31.51M 32.77M 34.8M 36.23M 37.87M 39.14M 36.92M 36.5M 42.85M 45.02M 44.85M 42.48M 32.69M 27.13M 24.65M 22.66M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
20.31M 27.93M 31.51M 32.77M 34.8M 36.23M 37.87M 39.14M 36.92M 36.5M 32.95M 35.12M 34.95M 32.68M 32.89M 27.33M 24.85M 22.76M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 7K -230K -232K -234K -243K -23K -21K -20K
Shares Outstanding (Basic)
98.56M 87.76M 612.02M 68.25M 57.63M 403.32M 32.13M 255.2M 255.13M 211.93M 189.05M 185.06M 182.58M 143.08M 142.87M 15.87M 137.43M 133.9M
Shares Outstanding (Diluted)
98.56M 87.76M 612.02M 68.25M 57.63M 403.32M 32.13M 255.2M 255.13M 211.93M 189.05M 185.06M 182.58M 143.08M 142.87M 15.87M 137.43M 133.9M
EPS (Basic)
-0.25 -0.31 -0.45 -0.69 -0.63 -0.53 -0.37 -0.17 -0.17 -0.54 -0.61 -0.61 -1.03 -0.92 -0.81 -0.82 -0.9 -1.26
EPS (Diluted)
-0.25 -0.31 -0.45 -0.69 -0.63 -0.53 -0.37 -0.17 -0.17 -0.54 -0.61 -0.61 -1.03 -0.92 -0.81 -0.82 -0.9 -1.26
EBITDA
-36.65M -37.4M -40.34M -32.1M -34.04M -35.47M -37.73M -38.6M -36.14M -35.43M -40.88M -43.5M -43.66M -39.78M -24.61M -17.15M -14.66M -14.38M
EBIT
-20.13M -27.75M -31.25M -32.65M -34.59M -35.81M -37.34M -38.33M -36.2M -35.99M -41.63M -44.13M -44.07M -40.06M -25.56M -18.1M -15.49M -15.3M
Depreciation & Amortization
-9.64M -9.64M n/a 9.64M 9.64M 9.8M 245K 368K 575K 499K 457K 1.61M 8.38M 12.75M 13.55M 16.43M 13.95M 13.76M